Phibro Animal Health Corporation and Zydus Cadila announce their intention to license Phibro's Poultry Vaccine Technologies

July 5, 2017 at 8:15 AM EDT

TEL AVIV, Israel and AHMEDABAD, India, July 05, 2017 (GLOBE NEWSWIRE) -- (NASDAQ:PAHC)

Phibro Animal Health Corporation and Zydus Cadila today announced their intention to enter into a long-term arrangement to license Phibro's innovative poultry vaccine technologies and know-how to a new vaccine manufacturing facility to be built by Zydus Cadila to serve the fast growing poultry market in India. 

Jack Bendheim, Chairman, President and Chief Executive Officer of Phibro, remarked, "We are proud of the more than 20-year partnership with Zydus Cadila serving the Indian animal health market and we view this as an exciting next step in our relationship." 

Speaking on the development Mr. Pankaj R. Patel, Chairman and Managing Director, Zydus group said, "Our endeavor has always been to enable access to innovative therapies across geographies and this agreement with Phibro will help bring innovations to the poultry market in India. The availability of new advanced poultry vaccines, which were until now being imported into India, adds a new dimension to the Make-in-India movement in the animal health segment."

About Zydus Animal Health

With a strong presence in the livestock and poultry segments, Zydus Animal Health  is India's leading animal healthcare player and a market leader in various therapeutic segments which include antibacterials, NSAIDs, antimastitis, tonics and poultry vaccines  amongst others in India. Zydus Animal Health has introduced the highest number of ‘First in India' products, in keeping with its mission to provide innovative solutions that improve animal health and farm productivity.

About Zydus Cadila

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.  The group employs over 20000 people worldwide and is dedicated to creating healthier communities globally.  The group aspires to be a research-based pharmaceutical company by 2020.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, dairy, beef cattle and aquaculture. For further information, please visit

Phibro Animal Health Corporation
Richard Johnson
Chief Financial Officer

Sujatha Rajesh
Vice President — Corporate Communications
Zydus Cadila